Digital infrared imaging developer Infrared Sciences has completed a placement of $1 million in preferred stock, according to the Hauppauge, NY-based firm.
The capital will be used to introduce the company's BreastScan IR, an infrared imaging product designed for use as an adjunctive test with mammography, ultrasound, or clinical examination for the early detection of breast cancer. The firm plans to provide BreastScan IR systems to qualified clinicians at no up-front cost on a fee-per-use basis, Infrared Sciences said.
By AuntMinnie.com staff writers
October 5, 2004
Related Reading
Infrared Sciences gets FDA nod for infrared breast imaging unit, February 26, 2004
Experimental infrared imager pinpoints tumor development in breast cancer, July 19, 2002
Copyright © 2004 AuntMinnie.com